Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 43675 of 46697 entries
View as:
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 15
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 25
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 24
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 20
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 20
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 11
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Vincenzo Cannizzaro | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Vincenzo Cannizzaro.temp.org | 2025-07-14 |
| Vincere Cancer Center | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Vincere Cancer Center.temp.org | 2025-07-14 |
| Vincerx Pharma, Inc. | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Vincerx Pharma, Inc..temp.org | 2025-07-14 |
| Vineet Punia MD | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Vineet Punia MD.temp.org | 2025-07-14 |
| Vinh Hoan Corporation | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Vinh Hoan Corporation.temp.org | 2025-07-14 |
| Vinicius Magno da Rocha, MD, MSc | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Vinicius Magno da Rocha, MD, MSc.temp.org | 2025-07-14 |
| Vinita Takiar | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Vinita Takiar.temp.org | 2025-07-14 |
| Vinmec Healthcare System | - | 15 | 0.0% | 0 | 0 | 0.0% | - | Vinmec Healthcare System.temp.org | 2025-07-14 |
| Vinmec Research Institute of Stem Cell and Gene Technology | - | 25 | 0.0% | 0 | 0 | 0.0% | - | Vinmec Research Institute of Stem Cell and Gene Technology.temp.org | 2025-07-14 |
| Vinodh Kakkassery, MD | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Vinodh Kakkassery, MD.temp.org | 2025-07-14 |
| Vinícius C Quintão, MD, MSc, PhD | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Vinícius C Quintão, MD, MSc, PhD.temp.org | 2025-07-14 |
| Violeta Pajero Otero | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Violeta Pajero Otero.temp.org | 2025-07-14 |
| Viome | - | 24 | 0.0% | 0 | 0 | 0.0% | - | Viome.temp.org | 2025-07-14 |
| Vion Pharmaceuticals | - | 20 | 0.0% | 0 | 0 | 0.0% | - | Vion Pharmaceuticals.temp.org | 2025-07-14 |
| Vir Biotechnology, Inc. | - | 20 | 0.0% | 0 | 0 | 0.0% | - | Vir Biotechnology, Inc..temp.org | 2025-07-14 |
| Viracta Therapeutics, Inc. | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Viracta Therapeutics, Inc..temp.org | 2025-07-14 |
| Viraj Master | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Viraj Master.temp.org | 2025-07-14 |
| Viral Hepatitis Society | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Viral Hepatitis Society.temp.org | 2025-07-14 |
| Viral N. Shah | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Viral N. Shah.temp.org | 2025-07-14 |
| ViralClear Pharmaceuticals, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ViralClear Pharmaceuticals, Inc..temp.org | 2025-07-14 |
| Viralytics | - | 11 | 0.0% | 0 | 0 | 0.0% | - | Viralytics.temp.org | 2025-07-14 |
| Viramal Limited | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Viramal Limited.temp.org | 2025-07-14 |
| Viravaxx AG | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Viravaxx AG.temp.org | 2025-07-14 |
| ViraxBio Labs | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ViraxBio Labs.temp.org | 2025-07-14 |
| Virchow Group | - | 5 | 0.0% | 0 | 0 | 0.0% | - | Virchow Group.temp.org | 2025-07-14 |